Loading chat...
PA HR892
Resolution
Status
Introduced
5/18/2016
Primary Sponsor
Frank Burns
Click for details
AI Summary
Legislative Description
Requesting the Congress of the United States to urge the Food and Drug Administration to reverse its directive allowing OxyContin to be prescribed to children 11 to 16 years of age.
Last Action
Referred to HEALTH
5/18/2016
Committee Referrals
Health5/18/2016
Full Bill Text
No bill text available